REGENERON PHARMACEUTICALS, INC. Restricted Cash and Investments, Noncurrent
REGENERON PHARMACEUTICALS, INC. (REGN) had Restricted Cash and Investments, Noncurrent of $0 as of 2013-12-31, per its 10-K filed 2014-02-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Investments, Noncurrent
us-gaap:RestrictedCashAndInvestmentsNoncurrent · last filed 2014-02-13
- 2013-12-31: Restricted Cash and Investments, Noncurrent $0.00.
- 2013-03-31: Restricted Cash and Investments, Noncurrent $8.49M.
- 2012-12-31: Restricted Cash and Investments, Noncurrent $8.19M.
- 2012-09-30: Restricted Cash and Investments, Noncurrent $8.17M.
| Period end | Restricted Cash and Investments, Noncurrent |
|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-02-13 |
| 2013-03-31 | $8.49M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $8.19M 10-K · filed 2014-02-13 |
| 2012-09-30 | $8.17M 10-Q · filed 2012-10-24 |
| 2012-06-30 | $8.14M 10-Q · filed 2012-07-25 |
| 2012-03-31 | $8.15M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $7.72M 10-K · filed 2013-02-15 |
| 2011-09-30 | $8.15M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $8.16M 10-Q · filed 2011-07-28 |
| 2011-03-31 | $7.52M 10-Q · filed 2011-05-03 |
| 2010-12-31 | $7.52M 10-K · filed 2012-02-21 |
| 2009-12-31 | $1.60M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |